Strengthen Your Bones Safely and Without Medication

Introducing Osteoboost, the first vibration belt specifically designed to reduce the decline in bone strength and bone density in postmenopausal women with osteopenia.

There is an Escalating Rate of Osteoporosis Despite 25 Years of Drug Treatment Options

1 in 2 women and 1 in 4 men over 50 will suffer a bone density related fracture

“Fearing Drugs’ Rare Side Effects, Millions Take their Chances With Osteoporosis”

— New York Times

Introducing Osteoboost

OsteoBoost is the first vibration belt specifically designed to reduce the loss of bone strength and bone density in postmenopausal women.


The Osteoboost Vibration Belt applies gentle mechanical stimulation to the hips and spine to improve bone strength.


Leveraging 15 years of published research (starting with NASA) proving that vibration at a precise amplitude and frequency stimulates bones, Osteoboost delivers the optimal therapeutic dose directly to the most vulnerable anatomy, the hips and lumbar spine.


Osteoboost has been studied in multiple National Institutes of Health (NIH) funded clinical trials, based on a successful pilot study that showed a significant reduction in bone turnover markers after just one treatment.


Comfortable and as easy as putting on a belt, one 30-minute treatment per day while doing chores or walking the dog makes Osteoboost easy to fit into any lifestyle.

Bone Mineral Density in Women Over Time

There are over 1 million hip and spine fractures each year due to osteopenia and osteoporosis

The Osteoboost Difference


In a recently published study, Osteoboost induced an acute reduction in bone loss activity as measured by the biomarker NTx (mean: 14%, p<0.001).


Pivotal trial results showed a dramatic reduction in the loss of vertebral bone strength and density as measured by CT Scan


Osteoboost can be used safely during osteopenia whereas medications are used typically for osteoporosis.


Compliance is high at over 80%.

Treatment Compliance Rate

Current medication treatments are used by less than 10% of patients for whom they are indicated and have a high rate of treatment discontinuation.

Osteoboost is easy and convenient to use, with high compliance and satisfaction ratings. 


How It Works

The Osteoboost Vibration Belt is simple to use, and includes an auto-shutoff feature that ends treatment after 30 minutes. Use daily or at least 5 days a week for full treatment effect.

Easy to attach velcro secures it around the waist.


Simply press power and it begins the gentle vibration treatment.


Once treatment begins, you can go about your business.


Chan et al., 2013. The potential benefits and inherent risks of vibration as a non-drug therapy for the prevention and treatment of osteoporosis. Curr Osteoporos Rep 11: p. 36-44. 

NASA Research Leads to Vibration Belt Technology

Developed from NASA proven technology, OsteoBoost takes vibration therapy to another level by delivering precise mechanical stimulation targeted to the areas of the body that need it most, the hips and spine.

Our Team

Laura Yecies

Chief Executive Officer, President

Serial entrepreneur, formerly CEO at SyncThink, Catch (acq. Apple), and SugarSync (acq. J2). led multiple successful brands at Check Point, Netscape, Yahoo. MBA from Harvard, MSFS Georgetown School of Foreign Service, AB Dartmouth College.

Pamela Peeke, MD

Chief Medical Officer

Expert in women’s health, menopause, and longevity, member of the National Menopause Foundation Medical Advisory Board and a Trustee on the American College of Sports Medicine Board.

Michael Jaasma

Co-founder, Chief Scientific Officer

Co-founder of BHT, 20 years as a technical lead in medical device development. PhD in orthopedic biomechanics from UC Berkeley. Former Reviewer and Branch Chief at the FDA in CDRH.

Daniel Beeler

Vice President, Operations

Operational leader at scale, highly experienced with technical, regulatory, clinical, and commercial medical device development. Former CEO at Cardiospire and CTO at SyncThink and Metascrape.

Derek Hillstrom

VP Engineering

20 years of medical device development and manufacturing at St Jude Medical, Autonomic Technologies and Niveus Medical

Gabriel Griego


Seasoned sales & marketing leader. Track-record of successfully designing and executing go-to-market for consumer/medical products. Led marketing for PowerBar, Game Ready, and AlterG.

Dave McGurl


Director of Regulatory Affairs at MCRA and expert in orthopedics and medical devices. worked for 7 years at the FDA in the premarket orthopedic devices as acting branch chief and senior premarket lead reviewer. 

Board Members

Laura Yecies


Serial entrepreneur, formerly CEO at SyncThink, Catch (acq. Apple), and SugarSync (acq. J2). led multiple successful brands at Check Point, Netscape, Yahoo.  MBA from Harvard Business School, MSFS Georgetown, AB Dartmouth College.

Shane Mangrum

Founder, MD

Physical Medicine and Rehabilitation (PM&R) physician at Polaris Spine in Atlanta, GA; Specialist in non-operative spine and musculoskeletal care. Dr. Mangrum is also a co-inventor of the OsteoBoost technology

Eric Meyer


Expert in launching novel consumer medical, health and wellness products. Led Sonicare™’s commercial efforts from launch to  #1 dollar share power toothbrush brand in the U.S., and to Inc. Magazine’s #1 fastest growing privately-held company. Prior to Sonicare, served in senior marketing and sales positions at LifeScan where he launched the One Touch™ blood glucose monitor. MBA from Stanford University

Jeani Delagardelle


Experienced venture investor and business leader who specializes in founding and developing healthcare technology companies, across all stages of development and therapeutic areas, for either acquisition or IPO. She is a Co-founder and former Managing Director of New Leaf Venture Partners, a leading life science venture capital firm, spun out of the Sprout Group. MBA from University of California Irvine

John Osborne


Managing Partner, Good Growth Capital.  Over a decade working various roles in the finance industry including in commercial banking, private banking and angel investing. Co-founded and Director of The Harbor Entrepreneur Center, Charleston. Executive Administrator of Charleston Angel Partners. B.S. in Finance from Charleston Southern University

Sam Goldberger


Co-Founder and Managing Partner of Ambit Health Ventures. Ophthalmologist and ophthalmic surgeon. . MD from Albert Einstein College of Medicine, and MBA from MIT Sloan. Led a successful ophthalmology practice roll up and founded a healthcare and life-science investing firm.

Marcie Hamilton


Medical device operations and program management leader, co-founded Potrero Medical and incubated Bone Health Technologies. Managed VIvaRay Inc. to successful acquisition by Varian Medical Systems.

Advisors & Investigators

Harold Rosen


Professor of Endocrinology at Harvard Medical School, Director Osteoporosis Prevention and Treatment Center at Beth Israel Deaconess Medical Center, leading expert in bone densitometry, biochemical markers of bone turnover and metabolic bone disease.

David B. Karpf


Professor of Endocrinology at Stanford University School of Medicine, Director Stanford Osteoporosis and Metabolic Bone Disease Clinic, leading researcher on Osteoporosis medications (Fosomax trial) and board member of American Bone Health

Dolores Shoback


Professor of Medicine, UCSF, Staff Physician San Francisco, VA, and board member of American Bone Health. Dr. Shoback is a recognized authority in metabolic bone disease, parathyroid disorders and osteoporosis. She also co-directs UCSF’s physician training program in diabetes, endocrinology and metabolism.

Anne Schafer


Chief of Endocrinology and Metabolism San Francisco, VA, Associate Professor of Medicine and Epidemiology & Biostatistics at UCSF.  Dr. Schafer is an expert on optimizing osteoporosis treatment and the relationships between bone, fat, and glucose metabolism.

Laura Bilek


Associate Dean for Research in the College of Allied Health Professions at the University of Nebraska Medical Center (UNMC). Expert in clinical research for the treatment of low bone mass.

Tony Keaveny


Professor of Mechanical Engineering and Bioengineering, UC Berkeley, director of the Berkeley Orthopaedic Biomechanics Lab; Expert in bone mechanics and inventor of VirtuOst.


Berkeley Angel Network

52 million Americans have Osteopenia

Now they have a good option to reduce their loss of bone strength
that is easy to use and fits into their daily lifestyle

Contact us

At this time OsteoBoost is not available for sale. Please fill out the form if you would like to be notified when the product is available.

* indicates required